UNSPSC 51131703: Streptokinase

This classification denotes an enzyme produced by hemolytic streptococci and which hydrolyzes amide linkages and serves as an activator of plasminogen, and is thus used in thrombolytic therapy, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 8X1OXL3SNU, chemically known as 4-cyclohexylpyrrolidine-2-carboxylic acid but generally known as streptokinase, which bears US NIH Compound Identifier 9815560.

UNSPSC 51131703 Streptokinase is a Commodity code with minimal recent state and local procurement activity. The single recent opportunity associated with this code—Sourcewell RFP #061626, posted May 12, 2026 with a June 16, 2026 response deadline—is tagged as a law enforcement equipment solicitation and bears no relation to streptokinase, a thrombolytic pharmaceutical. The mismatch between the code's nominal scope (a specific injectable drug) and the actual work being solicited (law enforcement equipment) indicates that this code does not reflect genuine state and local purchasing patterns for streptokinase or related products at present.

The Sourcewell RFP is a cooperative purchasing vehicle administered by the State of Minnesota on behalf of multiple Washington counties (Franklin, Grant, Grays Harbor, Chelan, and Yakima) and numerous other jurisdictions and public entities throughout the United States and Canada. However, the procurement itself is fundamentally misaligned with the streptokinase commodity code, suggesting either a tagging error in the source system or that state and local governments are not currently soliciting this pharmaceutical through standard procurement channels captured in recent notice activity. Vendors in pharmaceutical distribution or thrombolytic-agent sales should verify the accuracy of this code categorization before pursuing opportunities listed under it.